#Achillion Pharmaceuticals (ACHN)

GOOD NEWS AMGEN (AMGN) said its experimental drug AMG 416 aimed at treating hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients on dialysis has met its endpo...

Biogen Idec (BIIB) : The FDA approved Biogen Idec drug Plegridy -- a long-acting multiple sclerosis drug expected to replace its older big-selling Avonex treatment. The drug is intended to reduce rela...

With the Biotech Index rising tremendously year to date, We find it a loss of time writing about failures in clinical data coming from some firms we have nothing to do with, or have divorced long ago,...

ARIAD Completes Rolling Submission of New Drug Application for Ponatinib to the U.S. Food and Drug Administration ARIAD (ARIA):  Completed the rolling submission of the New Drug Application (NDA) for...

ILLUMINA (ILMN) We heard good news in three announcements made by  Illumina (ILMN)  this week. The first was about marketing   Illunina’s  TruSeq® Stranded mRNA and Total RNA Sample Preparation  Kits...

TRAVELING THROUGH THE DAY Let’s have a look on announced news, analysts’ opinions and discussions over serious subjects that might have an impact on drug developers, medical practice and patients....